GT Biopharma adjourns special shareholders meeting due to lack of quorum; reconvened Oct 10

GT Biopharma, Inc.

Special meeting on Sept 28 lacked quorum; adjourned to Oct 10, 2022 at 11 a.m. PST.
Record date remains Aug 8, 2022; prior votes count unless changed.
Proposal unchanged: ratify discretionary broker voting on authorized share reduction from 750M to 250M.
Company urges all shareholders to vote by Oct 9 to ensure quorum at reconvened meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.